NEW YORK (GenomeWeb News) – French molecular diagnostics company Genomic Vision today announced the launch of its initial public offering.

It plans to offer about 1.3 million shares of its stock at an expected price range of between €13.5 ($18.61) and €16.5 per share. At the midpoint of the range, the IPO is anticipated to raise about €20 million ($27.6 million), Genomic Vision said. The company plans to list its shares on Euronext Paris.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

Joel Achenbach explores at National Geographic why people find science difficult to believe.

In Science this week: gene linked to expansion of the human neocortex, and more.

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.